(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:733801 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP3K1 mRNA CTD PMID:22079256 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of MAP3K1 protein CTD PMID:17337753 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:733801 6480464 Dinitrochlorobenzene binds to MAP3K1 protein CTD PMID:32991956 17alpha-ethynylestradiol affects expression ISO RGD:733802 6480464 Ethinyl Estradiol affects the expression of MAP3K1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of MAP3K1 mRNA CTD PMID:12655037 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of MAP3K1 mRNA CTD PMID:20170705 17beta-estradiol multiple interactions ISO RGD:733801 6480464 [Estradiol co-treated with IGF1R mutant form] results in increased expression of MAP3K1 mRNA CTD PMID:23094148 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:22889935 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:733802 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:733802 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733802 6480464 Tetrachlorodibenzodioxin affects the expression of MAP3K1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP3K1 mRNA CTD PMID:33387578 2,5-hexanedione increases expression EXP 6480464 2, 5-hexanedione results in increased expression of MAP3K1 protein CTD PMID:31760062 2-methylcholine affects expression ISO RGD:733801 6480464 beta-methylcholine affects the expression of MAP3K1 mRNA CTD PMID:21179406 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of MAP3K1 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases methylation ISO RGD:733802 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of MAP3K1 exon CTD PMID:33297965 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of MAP3K1 mRNA CTD PMID:21346803 5-fluorouracil affects expression ISO RGD:733801 6480464 Fluorouracil affects the expression of MAP3K1 mRNA CTD PMID:34151400 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MAP3K1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of MAP3K1 mRNA CTD PMID:31881176 acetazolamide increases expression ISO RGD:733802 6480464 Acetazolamide results in increased expression of MAP3K1 mRNA CTD PMID:19274763 alachlor increases expression EXP 6480464 alachlor results in increased expression of MAP3K1 mRNA CTD PMID:12419858 aldehydo-D-glucose increases expression ISO RGD:733802 6480464 Glucose results in increased expression of MAP3K1 mRNA CTD PMID:24659233 aldehydo-D-glucose multiple interactions ISO RGD:733801 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 aldehydo-D-glucose multiple interactions ISO RGD:733802 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA] CTD PMID:24659233 all-trans-retinoic acid increases expression ISO RGD:733801 6480464 Tretinoin results in increased expression of MAP3K1 mRNA CTD PMID:23724009 all-trans-retinoic acid decreases expression ISO RGD:733801 6480464 Tretinoin results in decreased expression of MAP3K1 mRNA CTD PMID:33167477 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein CTD PMID:34896426 amino acid multiple interactions ISO RGD:733801 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Amino Acids CTD PMID:27278863 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAP3K1 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:733801 6480464 pyrazolanthrone inhibits the reaction [[MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate], pyrazolanthrone inhibits the reaction [MAP3K1 protein results in increased expression of ABCB1 mRNA] CTD PMID:15604272 , PMID:27278863 aristolochic acid A decreases expression ISO RGD:733801 6480464 aristolochic acid I results in decreased expression of MAP3K1 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:733801 6480464 Arsenic affects the methylation of MAP3K1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:733801 6480464 Arsenic affects the methylation of MAP3K1 gene CTD PMID:25304211 benzo[a]pyrene increases expression ISO RGD:733801 6480464 Benzo(a)pyrene results in increased expression of MAP3K1 protein CTD PMID:16041517 benzo[a]pyrene decreases methylation ISO RGD:733802 6480464 Benzo(a)pyrene results in decreased methylation of MAP3K1 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:733801 6480464 Benzo(a)pyrene results in decreased methylation of MAP3K1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:733801 6480464 Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased expression of MAP3K1 protein] CTD PMID:16041517 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733801 6480464 7 more ... CTD PMID:19150397 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of MAP3K1 mRNA CTD PMID:16648578 bisphenol A affects expression ISO RGD:733801 6480464 bisphenol A affects the expression of MAP3K1 mRNA CTD PMID:20170705 bisphenol A multiple interactions ISO RGD:733801 6480464 [MAP3K1 protein co-treated with bisphenol A] results in decreased expression of APOA1 mRNA CTD PMID:31842455 bisphenol A decreases expression ISO RGD:733802 6480464 bisphenol A results in decreased expression of MAP3K1 mRNA CTD PMID:33221593 bisphenol A increases expression ISO RGD:733801 6480464 bisphenol A results in increased expression of MAP3K1 mRNA CTD PMID:29275510 , PMID:33670352 bisphenol A decreases methylation ISO RGD:733802 6480464 bisphenol A results in decreased methylation of MAP3K1 promoter CTD PMID:27312807 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP3K1 mRNA CTD PMID:25181051 buta-1,3-diene decreases expression ISO RGD:733802 6480464 1, 3-butadiene results in decreased expression of MAP3K1 mRNA CTD PMID:29038090 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of MAP3K1 mRNA CTD PMID:19167457 cadmium dichloride increases expression ISO RGD:733801 6480464 Cadmium Chloride results in increased expression of MAP3K1 mRNA CTD PMID:32512071 caffeine increases phosphorylation ISO RGD:733801 6480464 Caffeine results in increased phosphorylation of MAP3K1 protein CTD PMID:35688186 calcitriol increases expression ISO RGD:733801 6480464 Calcitriol results in increased expression of MAP3K1 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO RGD:733802 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO RGD:733802 6480464 Nanotubes, Carbon results in increased expression of MAP3K1 mRNA CTD PMID:25620056 carboplatin decreases expression EXP 6480464 Carboplatin results in decreased expression of MAP3K1 mRNA CTD PMID:18172885 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of MAP3K1 mRNA CTD PMID:18172885 CGP 52608 multiple interactions ISO RGD:733801 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP3K1 gene] CTD PMID:28238834 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MAP3K1 mRNA CTD PMID:18172885 cisplatin increases expression ISO RGD:733802 6480464 Cisplatin results in increased expression of MAP3K1 mRNA CTD PMID:26546572 clozapine increases expression EXP 6480464 Clozapine results in increased expression of MAP3K1 mRNA CTD PMID:15860345 copper atom multiple interactions ISO RGD:733801 6480464 [Chelating Agents binds to Copper] which results in increased expression of MAP3K1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:733801 6480464 [Chelating Agents binds to Copper] which results in increased expression of MAP3K1 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:733801 6480464 Copper Sulfate results in increased expression of MAP3K1 mRNA CTD PMID:19549813 curcumin multiple interactions ISO RGD:733801 6480464 Curcumin inhibits the reaction [MAP3K1 protein results in increased expression of IVL mRNA], Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA] CTD PMID:17148446 , PMID:23452621 curcumin decreases expression ISO RGD:733801 6480464 Curcumin results in decreased expression of MAP3K1 mRNA CTD PMID:15713895 cyclosporin A decreases expression ISO RGD:733801 6480464 Cyclosporine results in decreased expression of MAP3K1 mRNA CTD PMID:20106945 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein CTD PMID:34896426 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein CTD PMID:34896426 D-glucose multiple interactions ISO RGD:733802 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA] CTD PMID:24659233 D-glucose multiple interactions ISO RGD:733801 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 D-glucose increases expression ISO RGD:733802 6480464 Glucose results in increased expression of MAP3K1 mRNA CTD PMID:24659233 dacarbazine decreases response to substance ISO RGD:733801 6480464 MAP3K1 protein modified form results in decreased susceptibility to Dacarbazine CTD PMID:15123733 dibutyl phthalate increases expression ISO RGD:733802 6480464 Dibutyl Phthalate results in increased expression of MAP3K1 mRNA CTD PMID:21266533 diclofenac increases expression ISO RGD:733802 6480464 Diclofenac results in increased expression of MAP3K1 mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO RGD:733802 6480464 Diethylstilbestrol results in increased expression of MAP3K1 mRNA CTD PMID:22467019 dioxygen multiple interactions ISO RGD:733801 6480464 3 more ... CTD PMID:23452621 dioxygen increases expression ISO RGD:733801 6480464 Oxygen deficiency results in increased expression of MAP3K1 mRNA CTD PMID:23452621 doxorubicin decreases expression ISO RGD:733801 6480464 Doxorubicin results in decreased expression of MAP3K1 mRNA CTD PMID:29803840 ellagic acid decreases expression ISO RGD:733801 6480464 Ellagic Acid results in decreased expression of MAP3K1 mRNA, Ellagic Acid results in decreased expression of MAP3K1 protein CTD PMID:23811531 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAP3K1 mRNA CTD PMID:29391264 enniatin decreases expression EXP 6480464 enniatins results in decreased expression of MAP3K1 mRNA CTD PMID:27163883 epoxiconazole increases expression ISO RGD:733802 6480464 epoxiconazole results in increased expression of MAP3K1 mRNA CTD PMID:35436446 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein CTD PMID:34896426 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of MAP3K1 mRNA CTD PMID:24793618 formaldehyde decreases expression ISO RGD:733801 6480464 Formaldehyde results in decreased expression of MAP3K1 mRNA CTD PMID:20655997 furan increases methylation EXP 6480464 furan results in increased methylation of MAP3K1 gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of MAP3K1 mRNA CTD PMID:26194646 geldanamycin increases expression ISO RGD:733801 6480464 geldanamycin results in increased expression of MAP3K1 mRNA CTD PMID:26705709 genistein multiple interactions ISO RGD:733801 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA] CTD PMID:23452621 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAP3K1 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MAP3K1 mRNA CTD PMID:33387578 glucose increases expression ISO RGD:733802 6480464 Glucose results in increased expression of MAP3K1 mRNA CTD PMID:24659233 glucose multiple interactions ISO RGD:733801 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 glucose multiple interactions ISO RGD:733802 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA] CTD PMID:24659233 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of MAP3K1 mRNA CTD PMID:15860345 heptachlor decreases expression ISO RGD:733801 6480464 Heptachlor results in decreased expression of MAP3K1 protein CTD PMID:9704902 hexachlorobenzene affects expression EXP 6480464 Hexachlorobenzene affects the expression of MAP3K1 mRNA CTD PMID:15159207 hyaluronic acid multiple interactions ISO RGD:733802 6480464 Hyaluronic Acid analog affects the localization of [MAP3K1 protein binds to CD44 protein] more ... CTD PMID:20159036 iohexol increases expression ISO RGD:733801 6480464 Iohexol results in increased expression of MAP3K1 mRNA CTD PMID:29705293 iopamidol increases expression ISO RGD:733801 6480464 Iopamidol results in increased expression of MAP3K1 mRNA CTD PMID:29705293 lipopolysaccharide multiple interactions ISO RGD:733802 6480464 3, 4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of MAP3K1 mRNA] CTD PMID:25843059 lipopolysaccharide increases expression ISO RGD:733802 6480464 Lipopolysaccharides results in increased expression of MAP3K1 mRNA CTD PMID:25843059 LY294002 multiple interactions ISO RGD:733802 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased activity of MAP3K1 protein] CTD PMID:11306679 microcystin-LR increases expression ISO RGD:733802 6480464 cyanoginosin LR results in increased expression of MAP3K1 mRNA CTD PMID:17654400 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of MAP3K1 mRNA CTD PMID:28954212 N-methyl-4-phenylpyridinium increases cleavage ISO RGD:733801 6480464 1-Methyl-4-phenylpyridinium results in increased cleavage of MAP3K1 protein CTD PMID:10737593 nickel sulfate affects response to substance ISO RGD:733802 6480464 MAP3K1 protein affects the susceptibility to nickel sulfate CTD PMID:18467339 nickel sulfate decreases expression ISO RGD:733801 6480464 nickel sulfate results in decreased expression of MAP3K1 mRNA CTD PMID:22714537 nickel sulfate multiple interactions ISO RGD:733802 6480464 [MAP3K1 protein co-treated with MAP3K2 protein] affects the susceptibility to nickel sulfate, MAP3K1 protein affects the reaction [nickel sulfate results in increased phosphorylation of MAPK8 protein] CTD PMID:18467339 o-anisidine decreases expression ISO RGD:733801 6480464 2-anisidine results in decreased expression of MAP3K1 mRNA CTD PMID:28089782 ochratoxin A decreases expression ISO RGD:733801 6480464 ochratoxin A results in decreased expression of MAP3K1 mRNA CTD PMID:30763683 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MAP3K1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:733802 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP3K1 mRNA CTD PMID:34911549 p-menthan-3-ol increases expression ISO RGD:733801 6480464 Menthol results in increased expression of MAP3K1 mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO RGD:733801 6480464 aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Paclitaxel results in increased cleavage of MAP3K1 protein] more ... CTD PMID:11160861 paclitaxel increases cleavage ISO RGD:733801 6480464 Paclitaxel results in increased cleavage of MAP3K1 protein CTD PMID:11160861 paclitaxel affects localization ISO RGD:733801 6480464 Paclitaxel affects the localization of MAP3K1 protein CTD PMID:11160861 paracetamol affects expression ISO RGD:733802 6480464 Acetaminophen affects the expression of MAP3K1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MAP3K1 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:733802 6480464 [2 more ... CTD PMID:25510870 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of MAP3K1 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:733802 6480464 Phenobarbital results in decreased expression of MAP3K1 mRNA CTD PMID:31836555 phenylephrine multiple interactions EXP 6480464 MEKK1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] CTD PMID:10727428 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733801 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate more ... CTD PMID:27278863 potassium chromate multiple interactions ISO RGD:733801 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP3K1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:733801 6480464 potassium chromate(VI) results in decreased expression of MAP3K1 mRNA CTD PMID:22079256 pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of MAP3K1 protein CTD PMID:34896426 quercetin increases expression ISO RGD:733801 6480464 Quercetin results in increased expression of MAP3K1 mRNA CTD PMID:23727915 quercetin increases phosphorylation ISO RGD:733801 6480464 Quercetin results in increased phosphorylation of MAP3K1 protein CTD PMID:35688186 resveratrol multiple interactions ISO RGD:733801 6480464 resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA] CTD PMID:23452621 resveratrol multiple interactions ISO RGD:733802 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA] CTD PMID:24659233 SB 203580 multiple interactions ISO RGD:733801 6480464 SB 203580 inhibits the reaction [[MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate] CTD PMID:27278863 silver atom decreases expression ISO RGD:733801 6480464 Silver analog results in decreased expression of MAP3K1 mRNA CTD PMID:24462830 silver atom decreases expression ISO RGD:733802 6480464 Silver results in decreased expression of MAP3K1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:733801 6480464 Silver analog results in decreased expression of MAP3K1 mRNA CTD PMID:24462830 silver(0) decreases expression ISO RGD:733802 6480464 Silver results in decreased expression of MAP3K1 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:733801 6480464 sodium arsenite results in decreased expression of MAP3K1 mRNA CTD PMID:22714537 sodium arsenite affects methylation ISO RGD:733801 6480464 sodium arsenite affects the methylation of MAP3K1 gene CTD PMID:28589171 sodium dichromate decreases expression ISO RGD:733802 6480464 sodium bichromate results in decreased expression of MAP3K1 mRNA CTD PMID:22155349 sodium dodecyl sulfate decreases expression EXP 6480464 Sodium Dodecyl Sulfate results in decreased expression of MAP3K1 mRNA CTD PMID:12815608 sodium fluoride decreases expression ISO RGD:733802 6480464 Sodium Fluoride results in decreased expression of MAP3K1 mRNA CTD PMID:27862939 sulindac sulfide decreases expression ISO RGD:733801 6480464 sulindac sulfide results in decreased expression of MAP3K1 mRNA CTD PMID:12734198 tamoxifen affects expression ISO RGD:733802 6480464 Tamoxifen affects the expression of MAP3K1 mRNA CTD PMID:17555576 Tanshinone I decreases expression ISO RGD:733801 6480464 tanshinone results in decreased expression of MAP3K1 mRNA CTD PMID:15849732 temozolomide increases expression ISO RGD:733801 6480464 Temozolomide results in increased expression of MAP3K1 mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:733802 6480464 Testosterone deficiency results in increased expression of MAP3K1 mRNA CTD PMID:33848595 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MAP3K1 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAP3K1 mRNA CTD PMID:23411599 , PMID:34492290 tipifarnib increases expression EXP 6480464 tipifarnib results in increased expression of MAP3K1 mRNA CTD PMID:16403772 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MAP3K1 mRNA CTD PMID:25729387 tungsten decreases expression ISO RGD:733802 6480464 Tungsten results in decreased expression of MAP3K1 mRNA CTD PMID:30912803 undecane decreases expression EXP 6480464 undecane results in decreased expression of MAP3K1 protein CTD PMID:17337753 urethane multiple interactions ISO RGD:733802 6480464 [Urethane co-treated with Freund's Adjuvant] results in increased expression of MAP3K1 mRNA more ... CTD PMID:11062179 , PMID:12400877 urethane decreases expression ISO RGD:733801 6480464 Urethane results in decreased expression of MAP3K1 mRNA CTD PMID:28818685 Urolithin A decreases expression ISO RGD:733801 6480464 3 more ... CTD PMID:23811531 valproic acid increases methylation ISO RGD:733801 6480464 Valproic Acid results in increased methylation of MAP3K1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:733801 6480464 Valproic Acid affects the expression of MAP3K1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:733801 6480464 Valproic Acid results in decreased expression of MAP3K1 mRNA CTD PMID:23179753 , PMID:28001369 vincristine decreases expression ISO RGD:733801 6480464 Vincristine results in decreased expression of MAP3K1 mRNA CTD PMID:23649840 vitamin E multiple interactions ISO RGD:733802 6480464 Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAP3K1 protein] CTD PMID:11062179 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of MAP3K1 mRNA CTD PMID:17074742 zinc dichloride multiple interactions ISO RGD:733802 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased activity of MAP3K1 protein], PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAP3K1 protein] CTD PMID:11306679 zinc dichloride increases activity ISO RGD:733802 6480464 zinc chloride results in increased activity of MAP3K1 protein CTD PMID:11306679 zinc sulfate decreases expression EXP 6480464 Zinc Sulfate results in decreased expression of MAP3K1 mRNA CTD PMID:17074742 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of MAP3K1 mRNA CTD PMID:17074742